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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.08.051Background: Until now, the pathophysiology of hepatic hydrothorax has been moot.
We discuss (on the basis of gross videothoracoscopy findings in 11 cases and the
literature) the pathogenesis and clinical presentation of this complex condition.
Methods: We prospectively studied 11 patients (age, 31-73 years; 6 men and 5
women) with refractory hepatic hydrothorax (Child-Pugh class B-C) who underwent
thoracoscopic repair of diaphragmatic defects. The diaphragmatic defects were
examined intraoperatively.
Results: The diaphragmatic defects stemming from hepatic hydrothorax were clas-
sified into 4 morphologic types: type I, no obvious defect (1 patient); type II, blebs
lying on the diaphragm (4 patients); type III, broken defects (fenestrations) in the
diaphragm (8 patients); and type IV, multiple gaps in the diaphragm (1 patient). The
type of diaphragmatic defect did not correlate with the volume occupied by the
pleural effusion in the preoperative chest radiograms.
Conclusions: The finding of this study allowed hepatic hydrothorax pathophysiol-
ogy to be directly visualized, and further studies concerning the treatment of hepatic
hydrothorax might be based on these mechanisms.
Hepatic hydrothorax (HH) has been observed in approximately 1% to 10% ofcirrhotic patients.1,2 This condition is defined as the presence, in a cirrhoticpatient, of massive pleural effusion in the absence of primary pulmonary or
cardiac disease.2 The real mechanism for HH is unclear, although many mechanisms
have been reported. Most findings have been obtained from autopsy reports.3-6
There is accumulating evidence that diaphragmatic defects have a role in those cases
of HH in which blebs or fenestrations allow peritoneopleural communication.4,7,8
To our knowledge, the relationship between diaphragmatic defects and HH has not
been systematically studied in living patients. On the assumption that diaphragmatic
defects might be involved in the pathogenesis of HH, we studied the effects of
thoracoscopic repair in a prospective trial involving patients with HH who were
refractory to medical treatment, including thoracentesis, diuretics, and
pleurodesis.
Patients and Methods
Between October 2002 and November 2003, 11 patients (age, 31-73 years; 6 men and 5
women) with Child-Pugh class B-C liver cirrhosis complicated by HH were prospectively
studied at the National Taiwan University Hospital. Their preoperative clinical features and
biochemical characteristics are summarized in Table 1. No patient with a past history of
pulmonary or cardiogenic causes was included. Of all patients, none ever had successful
management of their pleural effusions. The diagnosis of HH was confirmed on the basis of
the presence of a history of cirrhosis, physical examination, biochemical profile, chest
radiography, chest computed tomography, and radionuclide study. The pleural effusion
volume was estimated on the basis of chest radiography. All patients provided written
informed consent. Three of these patients had renal failure with regular hemodialysis. All
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for surgical intervention after medical treatment failure, including
minocyclin or picibanil pleurodesis, and 2 of these patients had
limited activity with bed rest only. The patients were scheduled for
surgical intervention as soon as possible to achieve early control of
respiratory failure. One patient was hospitalized initially at our
institution with septic shock caused by left-sided pneumonia. We
performed thoracoscopic repair of diaphragmatic defects because
impending respiratory failure and mortality would predicate in
bilateral pulmonary problems (massive pleural effusion in the right
side and lobar pneumonia in the left side).
Needle thoracentesis was carried out early to differentiate tran-
sudates from exudates in the course of the illness. If their pro-
thrombin time and partial thrombin time were prolonged, patients
routinely received platelet and fresh frozen plasma infusion to
correct thrombocytopenia stemming from splenomegaly and
bleeding tendency. After achievement of general anesthesia, the
videothoracoscopic instruments were inserted through 3 trocar
sites: a 10-mm trocar through the ninth intercostal space in the
midaxillary line for insertion of the optical unit and two 1.5-cm
wounds (one at an anterior site in the fifth intercostal space and the
other at a posterior site in the fourth intercostal space). A total of
200 mL of saline solution with 2 mL of methylene blue was
TABLE 1. Clinical demographics of patients with hepatic
Case
no.
Age
(y)/sex Clinical presentation
Radiologic
study Ascites
Albu
(g/d
1 66/M Alcoholic LC, child B,
chronic renal failure
Rt PE: 2/3
hemithorax
Present 2.
2 31/M Alcoholic LC, child C,
Septic shock, LLL
pneumonia, acute
renal failure
Rt tension
hydrothorax
Present 2.
3 61/M HBV, HCV, child C LC Rt PE: 2/3
hemithorax
Present 2.
4 56/F HBV, child C LC Rt PE: 2/3
hemithorax
Absent 3.
5 68/M HCV, child C LC, HCV Rt tension
hydrothorax
Present 2.
6 63/F Child C LC, HCV Rt tension
hydrothorax
Present 1.
7 73/F Child C LC, DM, UTI Rt PE: 2/3
hemithorax
Absent 4.
8 65/F Child C LC, HCV Rt PE: 2/3
hemithorax
Present 1.
9 69/F Child C LC Rt PE: 1/2
hemothorax
Present 2.
10 46/M Child C LC, HCV, DM,
chronic renal failure
Rt PE: 1/2
hemithorax
Present 3.
11 62/M Child C LC Bilateral
PE: 1/2
hemithorax
Present 2.
T-Bil, Total bilirubin; Plt, platelets; HH, hepatic hydrothorax; LC, liver cirrhos
hepatitis C virus; DM, diabetes mellitus; UTI, urinary tract infection.routinely injected into the peritoneal cavity through a 2-cm ab-
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the defects with 4-0 Prolene sutures and performed minocyclin
pleurodesis postoperatively.
Results
The operative findings of all the patients are summarized in
Table 1. The pleural fluid is characteristically a transudate
and is usually similar to that found in the peritoneal cavity.
The mean serum albumin concentration for all patients was
2.9  0.7 mg/dL. The values for serum bilirubin (mean
value, 2.6 2.3 mg/dL) and prothrombin time (mean value,
17.2  2.6 seconds) were significantly higher in these
patients. In 4 of the patients with HH, peritoneal and pleural
fluids also were available for analysis during an episode of
spontaneous bacterial peritonitis. The preoperative chemical
pleurodesis with minocyclin only caused mild adhesion at
the posterior surface of the pulmonary parenchyma in the
condition of massive pleural effusion.
All defects were located on the tendinous area of the
diaphragm, and one was near the orifice of the inferior vena
cava. We classified the diaphragmatic defects associated
othorax
T-Bil
(mg/
dL)
Plt
(
103)
Prothrombin
time (s)
Preoperative
period of HH
(mo)
No. of
preoperative
pleurodeses
Operative
finding
0.5 54 14.5 9 6 Type II,
III,
0.6 375 18.2 2 4 Type III
2.3 44 18.8 6 5 Type II,
III, IV
3.9 78 19.4 1 3 Type II,
III
8.2 41 22.8 4 6 Type II
2.9 79 16.6 1 4 Type III
3.3 48 16.7 2 6 Type III
0.7 40 17.6 2 3 Type III
4.3 76 15.6 2 3 Type III
0.6 183 13.5 2 2 Type II
1.1 68 15.4 3 4 Type III
, pleural effusion; Rt, right; LLL, left lower lobe; HBV, hepatitis B virus; HCV,hydr
min
L)
9
6
8
7
7
9
2
9
5
4
9
is; PEwith the development of HH into 4 morphologic types
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on the diaphragm (Figure 1); type III, broken defects (fen-
estrations) in the diaphragm (Figure 2); and type IV, mul-
tiple gaps in the diaphragm (Figure 3). The blebs were
possibly 1 to 2 cm in diameter. The type III broken defects
usually appeared in a streak-like arrangement. They were
round to ovoid, showed diffuse infiltrative margins, and
were composed of fenestrations and broken blebs. The
lymphatic tracts could be delineated in type III defects by
means of injection of methylene blue through the abdominal
wound. Leakage of many drops of fluid (oozing) from type
IV diaphragmatic defects was in some cases seen 10 min-
utes after suction drainage of the pleural effusion (Figure 3).
A diaphragmatic defect could not be determined accu-
rately in one patient. Type II (4 patients) and III (8 patients)
defects were more frequently observed. No relationship was
found between the type of diaphragmatic defect and the
volume of occupied pleural effusion. These 4 types of
diaphragmatic defects could occur simultaneously.
Discussion
The implications of studies on HH pathogenesis carried out
during the last 50 years remain unclear. Several explana-
tions for HH development have been proposed, including
hypoalbuminemia, azygous vein hypertension, leakage from
the thoracic duct, transdiaphragmatic lymphatic migration,
and pressure gradient–directed flow through diaphragmatic
defects.8 However, in one study the transdiaphragmatic flow
of ascitic fluid through a diaphragmatic defect was demon-
TABLE 2. The gross appearance of the diaphragmatic de-
fects of hepatic hydrothorax
Author
Type I:
No
obvious
defect
Type II:
Blebs
lying on
diaphragm
Type III:
Broken
defects
(fenestrations)
of the
diaphragm
Type IV:
Multiple
gaps of
the
diaphragm
Chen
and
coworkers,6
review
article
6 6
Kakizaki
and
coworkers,7
review
article
4 1 12
Current
report,
single
institution
1 4 8 1strated by using the intraperitoneal injection of air, dye, or
The Journal of ThoraciFigure 1. Type II diaphragmatic defect in HH (A-C). The blebs
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TSa radionuclide.9,10 Because of the small numbers of patients
studied, several key questions remain. Moreover, hepatitis
is a serious health problem in Taiwan. Liver cirrhosis and
hepatoma, which are both closely correlated with hepatitis B
and C, are among the 10 leading causes of death in Taiwan.
The prevalence of hepatitis B surface antigen and anti-
hepatitis C virus in Taiwan were 12.6% and 41.6%, respec-
tively.11 Review of the literature revealed that no method to
date has been proved directly, and the present study pro-
vides direct visualization of the gross appearance of dia-
phragmatic defects.
This report raises the question of whether repair of these
diaphragmatic defects decreases the risk of HH. It poses a
serious management challenge because these patients also
have multiple organ dysfunctions. Various modalities have
been used in the past, with varying degrees of success.
Video-assisted thoracoscopic repair of diaphragmatic de-
fects was reported recently.12,13 The magnification afforded
by the optical system allows for excellent localization of
diaphragmatic defects.
The relationship of diaphragmatic defects to HH might
be considered in decision making during operative treat-
ment. In localized defects, such as type II (blebs) and III
(fenestrations) defects, primary suturing is reasonable, but
in type IV (diffuse oozing) defects, only primary repair or
repeat pleurodesis might not benefit. Mesh, tissue glue, or
flap might be considered for interruption of persistent leak-
age from these diaphragmatic defects. They need further
evaluation to determine whether our findings could provide
some pathophysiologic basis. As the diaphragmatic blebs
progress and eventually rupture, type III defects might re-
sult. The source of diaphragmatic defects could be detected
Figure 3. Leakage of many drops of fluid (oozing) from a type IV
diaphragmatic defect in HH was noted in some cases.Figure 2. Type III diaphragmatic defect in HH. A, A different type
of diaphragmatic defect could occur simultaneously. B, Some
pigmented rough surfaces represent the lymphatic tract on the
diaphragm after methylene blue being injected into the peritoneal
cavity. C, Numerous bead-like rough surfaces can be seen on the
diaphragm.with intraperitoneal methylene blue injection, which guided
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defects. Macroscopically, a type III defect is characterized
by using a unique combination of clusters of lymphatic
tracts (Figure 2). This finding prompted us to investigate the
possible role of pleural effusion leakage from these lym-
phatic tracts. Diaphragmatic defects might occur in a variety
of sites but most commonly arise in the tendinous portion of
the diaphragm. These defects are usually difficult to observe
by using ultrasonography and magnetic resonance imaging
in type II and IV defects. Our observation could explain that
only the type III defect with large fenestrations could be
detected by using these imaging methods.14
In another opinion spontaneous bacterial empyema can
occur in 13% of cirrhotic patients who have HH both with
and without ascites.15-17 The pathogenesis of spontaneous
bacterial empyema remains unknown15 and might be ex-
plained by the communication between the diaphragmatic
defects. Finally, the finding of this study allowed HH patho-
physiology to be directly visualized. Further studies about
the treatment of HH might be based on these mechanisms.
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